Adam Feinberg
Arthur Hamerschlag Career Development Professor, Biomedical Engineering, Materials Science and Engineering
Courtesy Appointment, Mechanical Engineering
Arthur Hamerschlag Career Development Professor, Biomedical Engineering, Materials Science and Engineering
Courtesy Appointment, Mechanical Engineering
Adam Feinberg is the Arthur Hamerschlag Career Development Professor in the Departments of Biomedical Engineering and Materials Science and Engineering at Carnegie Mellon University, and is the principal investigator of the Regenerative Biomaterials & Therapeutics Group. He has been in a faculty position since 2010 and has been fortunate to receive funding from notable sources including the NIH Director's New Innovator Award, the NSF CAREER Award, and the Human Frontiers Science Program. This has allowed him to rapidly build a group that has trained over 11 Ph.D. students, 11 M.S. students, and 5 postdoctoral fellows. He has published over 40 peer-reviewed research articles and filed over 15 patent applications.
Feinberg's scientific interests are focused on cell-material interactions and understanding how guidance cues can be encoded in the extracellular space to organize multicellular assembly. His background is in materials science and tissue engineering, providing him with a unique skill set to complete this work. His laboratory is investigating protein-based materials composed of nanostructured extracellular matrix (ECM) proteins for application in a range of applications including muscle tissue engineering, corneal repair, and cancer. To tackle these problems they are using tools of nano- and micro-fabrication in concert with molecular biology and 3-D, live-cell imaging of engineered constructs. His lab has recently developed two novel techniques: (i) an ECM shrink-wrapping technique to build a basement membrane around groups of cells and (ii) a 3-D bioprinting approach that dramatically improves the structures that can be biofabricated using soft ECM gels such as collagen and fibrin.
2004 Ph.D., Biomedical Engineering, University of Florida
2002 MS, Biomedical Engineering, University of Florida
1999 BS, Materials Science and Engineering, Cornell University
CMU Engineering
We are one step closer to naturally compostable robots now that researchers at Carnegie Mellon can print actuators using a bio-ink made from seaweed.
Government of Canada’s New Frontiers in Research Fund
BME/MSE’s Adam Feinberg and his international colleagues have been awarded $23.6 million by the Government of Canada’s New Frontiers in Research Fund Transformation program to develop cutting-edge regenerative therapies for heart disease.
CMU Engineering
Multi-university team, led by Mechanical Engineering’s Vickie Webster-Wood, is building actuators for next generation sustainable bio-bots.
WIRED
BME/MSE’s Adam Feinberg was quoted in a WIRED article about “edgeless” engineered tissue that Columbia University Medical Center researchers are working on and, recently, successfully transplanted. Feinberg commented on the importance of vascular quality in tissues, and a path for making these technologies more available.
CMU Engineering
CMU researchers examine what’s happening in the field of 3D bioprinting, core challenges to overcome, and essential milestones on the horizon toward clinical translation.
CMU Engineering
Wenhuan Sun, Victoria Webster-Wood, and Adam Feinberg have created an open-source, commercially available fiber extruder to benefit future research with hydrogels and soft robotics.
The 2022 Engineering Faculty Awards winners have been announced.
CMU Engineering
Innovative research led by BME’s Rachelle Palchesko and Adam Feinberg is exploring the use of a new cell delivery method to help cells stick and stay where they’re needed most.
The New York Times
BME/MSE’s Adam Feinberg was quoted in a New York Times article about 3D printed ear implants made by 3DBio Therapeutics.
CMU Engineering
A team of collaborators from CMU and Boston University present a human model of heart and lung co-development during embryogenesis using lab-grown human induced pluripotent stem cells.
Politico
BME/MSE’s Adam Feinberg was quoted in the latest edition of POLITICO’s Future Pulse newsletter, on the benefits of 3D printing organs and future considerations for the industry.
CMU Engineering
Mayo Clinic and Carnegie Mellon University announced today a research agreement to transform organ transplantation. The institutions will bioengineer innovative approaches to address current barriers in organ transplantation.